{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:12:18Z","timestamp":1790759538310,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,31]],"date-time":"2020-05-31T00:00:00Z","timestamp":1590883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,31]],"date-time":"2020-05-31T00:00:00Z","timestamp":1590883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. of Cardiovasc. Trans. Res."],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Various cell-based therapies are currently investigated in an attempt to tackle the high morbidity and mortality associated with heart failure. The need for these therapies to move towards the clinic is pressing. Therefore, preclinical large animal studies that use non-autologous cells are needed to evaluate their potential. However, non-autologous cells are highly immunogenic and trigger immune rejection responses resulting in potential loss of efficacy. To overcome this issue, adequate immunosuppressive regimens are of imminent importance but clear guidelines are currently lacking. In this review, we assess the immunological barriers regarding non-autologous cell transplantation and immune modulation with immunosuppressive drugs. In addition, we provide recommendations with respect to immunosuppressive regimens in preclinical cardiac cell-replacement studies.<\/jats:p>","DOI":"10.1007\/s12265-020-10035-2","type":"journal-article","created":{"date-parts":[[2020,5,31]],"date-time":"2020-05-31T22:59:22Z","timestamp":1590965962000},"page":"88-99","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Requirements for Proper Immunosuppressive Regimens to Limit Translational Failure of Cardiac Cell Therapy in Preclinical Large Animal Models"],"prefix":"10.1007","volume":"14","author":[{"given":"Evelyne J.","family":"Demkes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Rijken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariusz K.","family":"Szymanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imo E.","family":"Hoefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost P. G.","family":"Sluijter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5233-0066","authenticated-orcid":false,"given":"Saskia C. A.","family":"de Jager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,31]]},"reference":[{"key":"10035_CR1","unstructured":"World Health Organization. (2018). Global health estimates 2016: deaths by cause, age, sex, by country and by region, 2000\u20132016. Geneva. Retrieved from https:\/\/www.who.int\/healthinfo\/global_burden_disease\/estimates\/en\/"},{"issue":"6","key":"10035_CR2","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nrcardio.2016.25","volume":"13","author":"B Ziaeian","year":"2016","unstructured":"Ziaeian, B., & Fonarow, G. C. (2016). Epidemiology and aetiology of heart failure. Nature Reviews Cardiology, 13(6), 368\u2013378. https:\/\/doi.org\/10.1038\/nrcardio.2016.25.","journal-title":"Nature Reviews Cardiology"},{"issue":"2","key":"10035_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1586\/erc.09.187","volume":"8","author":"LB Tan","year":"2010","unstructured":"Tan, L. B., Williams, S. G., Tan, D. K. H., & Cohen-Solal, A. (2010). So many definitions of heart failure: are they all universally valid? A critical appraisal. Expert Review of Cardiovascular Therapy, 8(2), 217\u2013228. https:\/\/doi.org\/10.1586\/erc.09.187.","journal-title":"Expert Review of Cardiovascular Therapy"},{"issue":"27","key":"10035_CR4","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., et al. (2016). 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal, 37(27), 2129\u20132200m. https:\/\/doi.org\/10.1093\/eurheartj\/ehw128.","journal-title":"European Heart Journal"},{"key":"10035_CR5","doi-asserted-by":"publisher","unstructured":"Branger, P., & Undine, S. (2018). Eurotransplant annual report 2018. Annual Report\/ Eurotransplant International Foundation. Leiden. https:\/\/doi.org\/10.3934\/math.2019.1.166.","DOI":"10.3934\/math.2019.1.166"},{"issue":"11","key":"10035_CR6","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1002\/ejhf.829","volume":"19","author":"A Mathur","year":"2017","unstructured":"Mathur, A., Arnold, R., Assmus, B., Bartunek, J., Belmans, A., B\u00f6nig, H., et al. (2017). The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: rationale and design of the BAMI trial. European Journal of Heart Failure, 19(11), 1545\u20131550. https:\/\/doi.org\/10.1002\/ejhf.829.","journal-title":"European Journal of Heart Failure"},{"issue":"3","key":"10035_CR7","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1093\/cvr\/cvz010","volume":"115","author":"R Madonna","year":"2019","unstructured":"Madonna, R., Van Laake, L. W., Botker, H. E., Davidson, S. M., De Caterina, R., Engel, F. B., et al. (2019). ESC working group on cellular biology of the heart: position paper for cardiovascular research: tissue engineering strategies combined with cell therapies for cardiac repair in ischaemic heart disease and heart failure. Cardiovascular Research, 115(3), 488\u2013500. https:\/\/doi.org\/10.1093\/cvr\/cvz010.","journal-title":"Cardiovascular Research"},{"issue":"11 SUPPL.1","key":"10035_CR8","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1161\/CIRCULATIONAHA.111.084343","volume":"126","author":"M Kawamura","year":"2012","unstructured":"Kawamura, M., Miyagawa, S., Miki, K., Saito, A., Fukushima, S., Higuchi, T., et al. (2012). Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation, 126(11 SUPPL.1), S29\u2013S37. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.084343.","journal-title":"Circulation"},{"issue":"1","key":"10035_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-08869-z","volume":"7","author":"M Kawamura","year":"2017","unstructured":"Kawamura, M., Miyagawa, S., Fukushima, S., Saito, A., Miki, K., Funakoshi, S., et al. (2017). Enhanced therapeutic effects of human iPS cell derived-cardiomyocyte by combined cell-sheets with omental flap technique in porcine ischemic cardiomyopathy model. Scientific Reports, 7(1), 1\u201311. https:\/\/doi.org\/10.1038\/s41598-017-08869-z.","journal-title":"Scientific Reports"},{"issue":"8","key":"10035_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0201650","volume":"13","author":"M Ishigami","year":"2018","unstructured":"Ishigami, M., Masumoto, H., Ikuno, T., Aoki, T., Kawatou, M., Minakata, K., et al. (2018). Human iPS cell-derived cardiac tissue sheets for functional restoration of infarcted porcine hearts. PLoS One, 13(8), 1\u201313. https:\/\/doi.org\/10.1371\/journal.pone.0201650.","journal-title":"PLoS One"},{"issue":"9","key":"10035_CR11","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/nprot.2015.089","volume":"10","author":"H Kempf","year":"2015","unstructured":"Kempf, H., Kropp, C., Olmer, R., Martin, U., & Zweigerdt, R. (2015). Cardiac differentiation of human pluripotent stem cells in scalable suspension culture. Nature Protocols, 10(9), 1345\u20131361. https:\/\/doi.org\/10.1038\/nprot.2015.089.","journal-title":"Nature Protocols"},{"key":"10035_CR12","doi-asserted-by":"publisher","unstructured":"Zhao, S., Xu, Z., Wang, H., Reese, B. E., Gushchina, L. V., Jiang, M., et al. (2016). Bioengineering of injectable encapsulated aggregates of pluripotent stem cells for therapy of myocardial infarction. Nature Communications, 7. https:\/\/doi.org\/10.1038\/ncomms13306.","DOI":"10.1038\/ncomms13306"},{"issue":"4","key":"10035_CR13","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nm1394","volume":"12","author":"WH Zimmermann","year":"2006","unstructured":"Zimmermann, W. H., Melnychenko, I., Wasmeier, G., Didi\u00e9, M., Naito, H., Nixdorff, U., et al. (2006). Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nature Medicine, 12(4), 452\u2013458. https:\/\/doi.org\/10.1038\/nm1394.","journal-title":"Nature Medicine"},{"issue":"40","key":"10035_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/adfm.201803151","volume":"28","author":"M Castilho","year":"2018","unstructured":"Castilho, M., van Mil, A., Maher, M., Metz, C. H. G., Hochleitner, G., Groll, J., et al. (2018). Melt electrowriting allows tailored microstructural and mechanical design of scaffolds to advance functional human myocardial tissue formation. Advanced Functional Materials, 28(40), 1\u201310. https:\/\/doi.org\/10.1002\/adfm.201803151.","journal-title":"Advanced Functional Materials"},{"issue":"10","key":"10035_CR15","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41569-018-0036-6","volume":"15","author":"H Hashimoto","year":"2018","unstructured":"Hashimoto, H., Olson, E. N., & Bassel-Duby, R. (2018). Therapeutic approaches for cardiac regeneration and repair. Nature Reviews Cardiology, 15(10), 585\u2013600. https:\/\/doi.org\/10.1038\/s41569-018-0036-6.","journal-title":"Nature Reviews Cardiology"},{"issue":"6","key":"10035_CR16","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1084\/jem.177.6.1643","volume":"177","author":"Z Liu","year":"1993","unstructured":"Liu, Z., Sun, Y. K., Xi, Y. P., Maffei, A., Reed, E., Harris, P., & Suciu-Foca, N. (1993). Contribution of direct and indirect recognition pathways to T cell alloreactivity. Journal of Experimental Medicine, 177(6), 1643\u20131650. https:\/\/doi.org\/10.1084\/jem.177.6.1643.","journal-title":"Journal of Experimental Medicine"},{"issue":"2","key":"10035_CR17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.imlet.2015.11.002","volume":"168","author":"S Campana","year":"2015","unstructured":"Campana, S., De Pasquale, C., Carrega, P., Ferlazzo, G., & Bonaccorsi, I. (2015). Cross-dressing: an alternative mechanism for antigen presentation. Immunology Letters, 168(2), 349\u2013354. https:\/\/doi.org\/10.1016\/j.imlet.2015.11.002.","journal-title":"Immunology Letters"},{"issue":"11","key":"10035_CR18","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.1096\/fj.08-107441","volume":"22","author":"K Brown","year":"2008","unstructured":"Brown, K., Sacks, S. H., & Wong, W. (2008). Extensive and bidirectional transfer of major histocompatibility complex class II molecules between donor and recipient cells in vivo following solid organ transplantation. The FASEB Journal, 22(11), 3776\u20133784. https:\/\/doi.org\/10.1096\/fj.08-107441.","journal-title":"The FASEB Journal"},{"issue":"14","key":"10035_CR19","doi-asserted-by":"publisher","first-page":"6586","DOI":"10.1073\/pnas.90.14.6586","volume":"90","author":"CD Gimmi","year":"1993","unstructured":"Gimmi, C. D., Freeman, G. J., Gribben, J. G., Gray, G., & Nadler, L. M. (1993). Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proceedings of the National Academy of Sciences of the United States of America, 90(14), 6586\u20136590. https:\/\/doi.org\/10.1073\/pnas.90.14.6586.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"JUN","key":"10035_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2016.00251","volume":"7","author":"K Pallmer","year":"2016","unstructured":"Pallmer, K., & Oxenius, A. (2016). Recognition and regulation of T cells by NK cells. Frontiers in Immunology, 7(JUN), 1\u201313. https:\/\/doi.org\/10.3389\/fimmu.2016.00251.","journal-title":"Frontiers in Immunology"},{"key":"10035_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-8546-3_1","volume":"1802","author":"CH Edgerly","year":"2018","unstructured":"Edgerly, C. H., & Weimer, E. T. (2018). The past, present, and future of HLA typing in transplantation. Methods in Molecular Biology, 1802, 1\u201310. https:\/\/doi.org\/10.1007\/978-1-4939-8546-3_1.","journal-title":"Methods in Molecular Biology"},{"issue":"3","key":"10035_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/af\/vfz014","volume":"9","author":"E Wolf","year":"2019","unstructured":"Wolf, E., Kemter, E., Klymiuk, N., & Reichart, B. (2019). Genetically modified pigs as donors of cells, tissues, and organs for xenotransplantation. Animal Frontiers, 9(3), 13\u201320. https:\/\/doi.org\/10.1093\/af\/vfz014.","journal-title":"Animal Frontiers"},{"issue":"5","key":"10035_CR23","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/tri.13104","volume":"31","author":"RPH Meier","year":"2018","unstructured":"Meier, R. P. H., Muller, Y. D., Balaphas, A., Morel, P., Pascual, M., Seebach, J. D., & Buhler, L. H. (2018). Xenotransplantation: back to the future? Transplant International, 31(5), 465\u2013477. https:\/\/doi.org\/10.1111\/tri.13104.","journal-title":"Transplant International"},{"issue":"10","key":"10035_CR24","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.healun.2011.08.003","volume":"30","author":"J Stehlik","year":"2011","unstructured":"Stehlik, J., Edwards, L. B., Kucheryavaya, A. Y., Benden, C., Christie, J. D., Dobbels, F., et al. (2011). The registry of the international society for heart and lung transplantation: twenty-eighth adult heart transplant report-2011. Journal of Heart and Lung Transplantation, 30(10), 1078\u20131094. https:\/\/doi.org\/10.1016\/j.healun.2011.08.003.","journal-title":"Journal of Heart and Lung Transplantation"},{"key":"10035_CR25","doi-asserted-by":"publisher","unstructured":"Penninga, L., M\u00f8ller, C. H., Gustafsson, F., Gluud, C., & Steinbr\u00fcchel, D. A. (2013). Immunosuppressive T-cell antibody induction for heart transplant recipients. Cochrane Database of Systematic Reviews, 2013(12). https:\/\/doi.org\/10.1002\/14651858.CD008842.pub2.","DOI":"10.1002\/14651858.CD008842.pub2"},{"issue":"2","key":"10035_CR26","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2215\/CJN.08570814","volume":"11","author":"AC Wiseman","year":"2016","unstructured":"Wiseman, A. C. (2016). Immunosuppressive medications. Clinical Journal of the American Society of Nephrology, 11(2), 332\u2013343. https:\/\/doi.org\/10.2215\/CJN.08570814.","journal-title":"Clinical Journal of the American Society of Nephrology"},{"issue":"1","key":"10035_CR27","first-page":"136","volume":"75","author":"J Andersson","year":"1992","unstructured":"Andersson, J., Nagy, S., Groth, C. G., & Andersson, U. (1992). Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level. Immunology, 75(1), 136\u2013142.","journal-title":"Immunology"},{"issue":"10","key":"10035_CR28","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/FPC.0b013e328364db84.PharmGKB","volume":"23","author":"JM Barbarino","year":"2013","unstructured":"Barbarino, J. M., Staatz, C. E., Venkataramanan, R., Klein, T. E., & Altman, R. B. (2013). PharmGKB summary: cyclosporine and tacrolimus pathways. Pharmacogenetics and Genomics, 23(10), 563\u2013585. https:\/\/doi.org\/10.1097\/FPC.0b013e328364db84.PharmGKB.","journal-title":"Pharmacogenetics and Genomics"},{"issue":"4","key":"10035_CR29","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/0092-8674(91)90124-H","volume":"66","author":"J Liu","year":"1991","unstructured":"Liu, J., Farmer, J. D., Lane, W. S., Friedman, J., Weissman, I., & Schreiber, S. L. (1991). Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell, 66(4), 807\u2013815. https:\/\/doi.org\/10.1016\/0092-8674(91)90124-H.","journal-title":"Cell"},{"issue":"6","key":"10035_CR30","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1111\/j.1600-6143.2006.01300.x","volume":"6","author":"M Grimm","year":"2006","unstructured":"Grimm, M., Rinaldi, M., Yonan, N. A., Arpesella, G., Ariz\u00f3n Del Prado, J. M., Pulp\u00f3n, L. A., et al. (2006). Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients - a large European trial. American Journal of Transplantation, 6(6), 1387\u20131397. https:\/\/doi.org\/10.1111\/j.1600-6143.2006.01300.x.","journal-title":"American Journal of Transplantation"},{"issue":"7520","key":"10035_CR31","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1136\/bmj.38569.471007.AE","volume":"331","author":"AC Webster","year":"2005","unstructured":"Webster, A. C., Woodroffe, R. C., Taylor, R. S., Chapman, J. R., & Craig, J. C. (2005). Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: Meta-analysis and meta-regression of randomised trial data. British Medical Journal, 331(7520), 810\u2013814. https:\/\/doi.org\/10.1136\/bmj.38569.471007.AE.","journal-title":"British Medical Journal"},{"issue":"9","key":"10035_CR32","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.7164\/antibiotics.40.1256","volume":"40","author":"T Kino","year":"1987","unstructured":"Kino, T., Hatanaka, H., Miyata, S., Inamura, N., Nishiyama, M., Yajima, T., et al. (1987). Fk-506, a novel immunosuppressant isolated from a Streptomyces ii. immunosuppressive effect of Fk-506 in vitro. The Journal of Antibiotics, 40(9), 1256\u20131265. https:\/\/doi.org\/10.7164\/antibiotics.40.1256.","journal-title":"The Journal of Antibiotics"},{"issue":"6","key":"10035_CR33","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00277-017-2975-0","volume":"96","author":"IS Moiseev","year":"2017","unstructured":"Moiseev, I. S., Burmina, E. A., Muslimov, A. R., Pirogova, O. V., Bondarenko, S. N., Darskaya, E. I., et al. (2017). Pharmacokinetic comparison of cyclosporin A and tacrolimus in graft-versus-host disease prophylaxis. Annals of Hematology, 96(6), 935\u2013942. https:\/\/doi.org\/10.1007\/s00277-017-2975-0.","journal-title":"Annals of Hematology"},{"issue":"August","key":"10035_CR34","doi-asserted-by":"publisher","first-page":"121772","DOI":"10.1016\/j.jchromb.2019.121772","volume":"1128","author":"D Krn\u00e1\u010d","year":"2019","unstructured":"Krn\u00e1\u010d, D., Reiffov\u00e1, K., & Rolinski, B. (2019). A new HPLC-MS\/MS method for simultaneous determination of cyclosporine A, tacrolimus, sirolimus and everolimus for routine therapeutic drug monitoring. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 1128(August), 121772. https:\/\/doi.org\/10.1016\/j.jchromb.2019.121772.","journal-title":"Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences"},{"issue":"16","key":"10035_CR35","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1056\/NEJMra050541","volume":"353","author":"T Rhen","year":"2005","unstructured":"Rhen, T., & Cidlowski, J. A. (2005). Antiinflammatory action of glucocorticoids - new mechanisms for old drugs. New England Journal of Medicine, 353(16), 1711\u20131723. https:\/\/doi.org\/10.1056\/NEJMra050541.","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10035_CR36","first-page":"23","volume":"99","author":"RNJ De Nijs","year":"2008","unstructured":"De Nijs, R. N. J. (2008). Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options. Minerva Medica, 99(1), 23\u201343.","journal-title":"Minerva Medica"},{"issue":"1","key":"10035_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1677\/JOE-07-0606","volume":"197","author":"O Schakman","year":"2008","unstructured":"Schakman, O., Gilson, H., & Thissen, J. P. (2008). Mechanisms of glucocorticoid-induced myopathy. Journal of Endocrinology, 197(1), 1\u201310. https:\/\/doi.org\/10.1677\/JOE-07-0606.","journal-title":"Journal of Endocrinology"},{"issue":"4","key":"10035_CR38","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1517\/14740338.2016.1140743","volume":"15","author":"M Oray","year":"2016","unstructured":"Oray, M., Abu Samra, K., Ebrahimiadib, N., Meese, H., & Foster, C. S. (2016). Long-term side effects of glucocorticoids. Expert Opinion on Drug Safety, 15(4), 457\u2013465. https:\/\/doi.org\/10.1517\/14740338.2016.1140743.","journal-title":"Expert Opinion on Drug Safety"},{"issue":"3","key":"10035_CR39","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/art.21984","volume":"55","author":"JR Curtis","year":"2006","unstructured":"Curtis, J. R., Westfall, A. O., Allison, J., Bijlsma, J. W., Freeman, A., George, V., et al. (2006). Population-based assessment of adverse events associated with long-term glucocorticoid use. Arthritis Care and Research, 55(3), 420\u2013426. https:\/\/doi.org\/10.1002\/art.21984.","journal-title":"Arthritis Care and Research"},{"issue":"9","key":"10035_CR40","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/FPC.0b013e328334338f","volume":"20","author":"G Zaza","year":"2010","unstructured":"Zaza, G., Cheok, M., Krynetskaia, N., Thorn, C., Stocco, G., Hebert, J. M., et al. (2010). Thiopurine pathway. Pharmacogenetics and Genomics, 20(9), 573\u2013574. https:\/\/doi.org\/10.1097\/FPC.0b013e328334338f Thiopurine.","journal-title":"Pharmacogenetics and Genomics"},{"issue":"2","key":"10035_CR41","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1074\/jbc.M204243200","volume":"278","author":"L Somerville","year":"2003","unstructured":"Somerville, L., Krynetski, E. Y., Krynetskaia, N. F., Beger, R. D., Zhang, W., Marhefka, C. A., et al. (2003). Structure and dynamics of thioguanine-modified duplex DNA. Journal of Biological Chemistry, 278(2), 1005\u20131011. https:\/\/doi.org\/10.1074\/jbc.M204243200.","journal-title":"Journal of Biological Chemistry"},{"issue":"10","key":"10035_CR42","doi-asserted-by":"publisher","first-page":"4986","DOI":"10.4049\/jimmunol.170.10.4986","volume":"170","author":"L Qu\u00e9m\u00e9neur","year":"2003","unstructured":"Qu\u00e9m\u00e9neur, L., Gerland, L.-M., Flacher, M., Ffrench, M., Revillard, J.-P., & Genestier, L. (2003). Differential control of cell cycle, proliferation, and survival of primary T lymphocytes by purine and pyrimidine nucleotides. The Journal of Immunology, 170(10), 4986\u20134995. https:\/\/doi.org\/10.4049\/jimmunol.170.10.4986.","journal-title":"The Journal of Immunology"},{"issue":"8","key":"10035_CR43","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1172\/JCI16432","volume":"111","author":"I Tiede","year":"2003","unstructured":"Tiede, I., Fritz, G., Strand, S., Poppe, D., Dvorsky, R., Strand, D., et al. (2003). CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes. Journal of Clinical Investigation, 111(8), 1133\u20131145. https:\/\/doi.org\/10.1172\/JCI16432.","journal-title":"Journal of Clinical Investigation"},{"issue":"1","key":"10035_CR44","doi-asserted-by":"publisher","first-page":"640","DOI":"10.4049\/jimmunol.176.1.640","volume":"176","author":"D Poppe","year":"2006","unstructured":"Poppe, D., Tiede, I., Fritz, G., Becker, C., Bartsch, B., Wirtz, S., et al. (2006). Azathioprine suppresses ezrin-radixin-moesin-dependent T cell-APC conjugation through inhibition of Vav guanosine exchange activity on Rac proteins. The Journal of Immunology, 176(1), 640\u2013651. https:\/\/doi.org\/10.4049\/jimmunol.176.1.640.","journal-title":"The Journal of Immunology"},{"issue":"2\u20133","key":"10035_CR45","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","volume":"47","author":"AC Allison","year":"2000","unstructured":"Allison, A. C., & Eugui, E. M. (2000). Mycophenolate mofetil and its mechanisms of action. Immunopharmacology, 47(2\u20133), 85\u2013118. https:\/\/doi.org\/10.1016\/S0162-3109(00)00188-0.","journal-title":"Immunopharmacology"},{"issue":"3","key":"10035_CR46","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.trre.2015.02.005","volume":"29","author":"C S\u00f6derlund","year":"2015","unstructured":"S\u00f6derlund, C., & R\u00e5degran, G. (2015). Immunosuppressive therapies after heart transplantation - the balance between under- and over-immunosuppression. Transplantation Reviews, 29(3), 181\u2013189. https:\/\/doi.org\/10.1016\/j.trre.2015.02.005.","journal-title":"Transplantation Reviews"},{"issue":"5","key":"10035_CR47","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.healun.2005.02.002","volume":"24","author":"HJ Eisen","year":"2005","unstructured":"Eisen, H. J., Kobashigawa, J., Keogh, A., Bourge, R., Renlund, D., Mentzer, R., et al. (2005). Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients. Journal of Heart and Lung Transplantation, 24(5), 517\u2013525. https:\/\/doi.org\/10.1016\/j.healun.2005.02.002.","journal-title":"Journal of Heart and Lung Transplantation"},{"issue":"6","key":"10035_CR48","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1016\/j.transproceed.2009.06.031","volume":"41","author":"M Dandel","year":"2009","unstructured":"Dandel, M., Jasaityte, R., Lehmkuhl, H., Knosalla, C., & Hetzer, R. (2009). Maintenance immunosuppression with mycophenolate mofetil: long-term efficacy and safety after heart transplantation. Transplantation Proceedings, 41(6), 2585\u20132588. https:\/\/doi.org\/10.1016\/j.transproceed.2009.06.031.","journal-title":"Transplantation Proceedings"},{"issue":"12","key":"10035_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0143953","volume":"10","author":"JMIH Gho","year":"2015","unstructured":"Jansen of Lorkeers, S. J, Gho, J. M. I. H., Koudstaal, S., Van Hout, G. P. J., Zwetsloot, P. P. M., Van Oorschot, J. W. M., et al. (2015). Xenotransplantation of human cardiomyocyte progenitor cells does not improve cardiac function in a porcine model of chronic ischemic heart failure. Results from a randomized, blinded, placebo controlled trial. PLoS One, 10(12), 1\u201319. https:\/\/doi.org\/10.1371\/journal.pone.0143953.","journal-title":"PLoS One"},{"issue":"23","key":"10035_CR50","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1016\/j.jacc.2008.06.052","volume":"52","author":"N Takehara","year":"2008","unstructured":"Takehara, N., Tsutsumi, Y., Tateishi, K., Ogata, T., Tanaka, H., Ueyama, T., et al. (2008). Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction. Journal of the American College of Cardiology, 52(23), 1858\u20131865. https:\/\/doi.org\/10.1016\/j.jacc.2008.06.052.","journal-title":"Journal of the American College of Cardiology"},{"key":"10035_CR51","doi-asserted-by":"publisher","unstructured":"Ye, L., Chang, Y.-H. H., Xiong, Q., Zhang, P., Zhang, L., Somasundaram, P., et al. (2014). Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells. Cell Stem Cell. https:\/\/doi.org\/10.1016\/j.stem.2014.11.009.","DOI":"10.1016\/j.stem.2014.11.009"},{"issue":"11","key":"10035_CR52","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1111\/j.1582-4934.2012.01594.x","volume":"16","author":"TIG Van der Spoel","year":"2012","unstructured":"Van der Spoel, T. I. G., Vrijsen, K. R., Koudstaal, S., Sluijter, J. P. G., Nijsen, J. F. W., de Jong, H. W., et al. (2012). Transendocardial cell injection is not superior to intracoronary infusion in a porcine model of ischaemic cardiomyopathy: a study on delivery efficiency. Journal of Cellular and Molecular Medicine, 16(11), 2768\u20132776. https:\/\/doi.org\/10.1111\/j.1582-4934.2012.01594.x.","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"7625","key":"10035_CR53","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nature19815","volume":"538","author":"Y Shiba","year":"2016","unstructured":"Shiba, Y., Gomibuchi, T., Seto, T., Wada, Y., Ichimura, H., Tanaka, Y., et al. (2016). Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts. Nature, 538(7625), 388\u2013391. https:\/\/doi.org\/10.1038\/nature19815.","journal-title":"Nature"},{"issue":"2","key":"10035_CR54","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1161\/CIRCULATIONAHA.112.131110","volume":"127","author":"AR Williams","year":"2013","unstructured":"Williams, A. R., Hatzistergos, K. E., Addicott, B., McCall, F., Carvalho, D., Suncion, V., et al. (2013). Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. Circulation, 127(2), 213\u2013223. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.131110.","journal-title":"Circulation"},{"issue":"7504","key":"10035_CR55","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nature13233","volume":"510","author":"JJH Chong","year":"2014","unstructured":"Chong, J. J. H., Yang, X., Don, C. W., Minami, E., Liu, Y. W., Weyers, J. J., et al. (2014). Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature, 510(7504), 273\u2013277. https:\/\/doi.org\/10.1038\/nature13233.","journal-title":"Nature"},{"issue":"7","key":"10035_CR56","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nbt.4162","volume":"36","author":"YW Liu","year":"2018","unstructured":"Liu, Y. W., Chen, B., Yang, X., Fugate, J. A., Kalucki, F. A., Futakuchi-Tsuchida, A., et al. (2018). Human embryonic stem cell-derived cardiomyocytes restore function in infarcted hearts of non-human primates. Nature Biotechnology, 36(7), 597\u2013605. https:\/\/doi.org\/10.1038\/nbt.4162.","journal-title":"Nature Biotechnology"},{"issue":"5","key":"10035_CR57","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.stemcr.2019.04.005","volume":"12","author":"R Romagnuolo","year":"2019","unstructured":"Romagnuolo, R., Masoudpour, H., Porta-S\u00e1nchez, A., Qiang, B., Barry, J., Laskary, A., et al. (2019). Human embryonic stem cell-derived cardiomyocytes regenerate the infarcted pig heart but induce ventricular tachyarrhythmias. Stem Cell Reports, 12(5), 967\u2013981. https:\/\/doi.org\/10.1016\/j.stemcr.2019.04.005.","journal-title":"Stem Cell Reports"},{"issue":"7","key":"10035_CR58","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1161\/CIRCRESAHA.117.311578","volume":"122","author":"K Zhu","year":"2018","unstructured":"Zhu, K., Wu, Q., Ni, C., Zhang, P., Zhong, Z., Wu, Y., et al. (2018). Lack of remuscularization following transplantation of human embryonic stem cell-derived cardiovascular progenitor cells in infarcted nonhuman primates. Circulation Research, 122(7), 958\u2013969. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.311578.","journal-title":"Circulation Research"},{"issue":"3","key":"10035_CR59","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.stemcr.2016.01.012","volume":"6","author":"T Kawamura","year":"2016","unstructured":"Kawamura, T., Miyagawa, S., Fukushima, S., Maeda, A., Kashiyama, N., Kawamura, A., et al. (2016). Cardiomyocytes derived from MHC-homozygous induced pluripotent stem cells exhibit reduced allogeneic immunogenicity in MHC-matched non-human primates. Stem Cell Reports, 6(3), 312\u2013320. https:\/\/doi.org\/10.1016\/j.stemcr.2016.01.012.","journal-title":"Stem Cell Reports"},{"issue":"2","key":"10035_CR60","first-page":"285","volume":"16","author":"B Frey","year":"1987","unstructured":"Frey, B., Sieber, M., Mettler, D., G\u00e4nger, H., & Frey, F. (1987). Marked interspicies differences between humans and pigs in cyclosporin and prednisolone disposition. Drug Metabolism and Disposition: The Biological Fate of Chemicals, 16(2), 285\u2013289.","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-020-10035-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12265-020-10035-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-020-10035-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,30]],"date-time":"2021-05-30T23:07:39Z","timestamp":1622416059000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12265-020-10035-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,31]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10035"],"URL":"https:\/\/doi.org\/10.1007\/s12265-020-10035-2","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,31]]},"assertion":[{"value":"12 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"No human or animal studies were carried out by the authors for this review article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"No informed consent was needed for this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}